A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C.
We have analyzed a series of HLA region markers in 207 UK Caucasoids with early-onset myasthenia gravis (EOMG, onset before age 40), where there is a strong female bias. The well known associations with HLA-DR3 and -B8 have now proved to be significantly stronger in the 165 females than in the 42 males. In patients (of either sex) lacking -DR3, there was also a significant increase in HLA-DR2. Although the muscle weakness in EOMG is clearly mediated by autoantibodies, the associations are consistently stronger with HLA-B8 (in class I) than with HLADR3 (in class II), as confirmed here. We therefore typed 87-137 cases for polymorphisms at four loci in the intervening class III region, and also at three in the adjacent stretch of class I. At each locus, one allele tended to co-occur with HLA-B8 and showed strong and highly significant associations in the patients. There appeared to be a region of maximal susceptibility extending from HSP70 (in class III) past HLA-B and HLA-C at least 600 kb telomerically into the class I region, which is now being mapped in detail. Any candidate genes here that act shortly after puberty may allow more precise localization of susceptibility.
Janer
M
M
Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Cowland
A
A
Picard
J
J
Campbell
D
D
Pontarotti
P
P
Newsom-Davis
J
J
Bunce
M
M
Welsh
K
K
Demaine
A
A
Wilson
A G
AG
Willcox
N
N
D000328:Adult; D004198:Disease Susceptibility; D005260:Female; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D015795:HLA-B8 Antigen / Q000235:genetics; D015236:HLA-C Antigens / Q000235:genetics*; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D009157:Myasthenia Gravis / Q000235:genetics* / Q000276:immunology; D016615:Telomere
D005819:Genetic Markers; D015795:HLA-B8 Antigen; D015236:HLA-C Antigens